Investment Rating - The report maintains a "Buy" rating for the company [6] Core Views - The company reported a total revenue of 20.682 billion yuan for the first half of 2025, a year-on-year decrease of 44.58%, and a net profit attributable to shareholders of 1.032 billion yuan, down 64.85% year-on-year [1] - The coal production and sales have recovered, and the company continues to implement cost reduction and efficiency enhancement measures [2] - The company is advancing its non-coal business steadily, including projects in the chemical and renewable energy sectors [4] Summary by Sections Financial Performance - In Q2 2025, the company achieved a revenue of 10.083 billion yuan, a decrease of 49.47% year-on-year, with a net profit of 340 million yuan, down 74.72% year-on-year [1] - The company’s coal production capacity includes 16 coal mines with a total capacity of 34.25 million tons per year, and it has closed the Zhuozhuang coal mine due to resource depletion [3] - The company’s financial projections for 2025 to 2027 estimate net profits of 2.6 billion yuan, 3.5 billion yuan, and 4.2 billion yuan respectively, with corresponding P/E ratios of 13.6X, 10.1X, and 8.5X [4][5] Business Development - The company is expanding its chemical production, with projects yielding qualified products, and is also increasing its renewable energy output, generating 104 million kWh from solar power and 102 million kWh from gas [4] - The company is actively pursuing new mining rights and has commenced construction on the Lei Ming Kehua project in Henan [4] Market Position - The company’s coal sales volume for the first half of 2025 was 8.91 million tons, a decrease of 13.7% year-on-year, while the average selling price of coal fell by 27% year-on-year to 835 yuan per ton [10] - The report highlights the company's strategic focus on enhancing its coal and chemical business while diversifying into non-coal sectors [3][4]

Investment Rating - The investment rating for the company is "Buy" (maintained) [2] Core Views - The company reported a slight decline in revenue and profit for the first half of 2025, with total revenue of 1.292 billion yuan, down 0.51% year-on-year, and a net profit attributable to shareholders of 367 million yuan, down 11.92% year-on-year [5][6] - The main business of the company has stabilized, with the biopharmaceutical segment showing growth driven by new product launches, particularly the antibody drug "安赛汀" which saw a sales increase of 298% [6][7] - The company has made significant progress in BD collaborations, introducing two major long-acting products to enhance its market position in pediatric growth and assisted reproduction [7] - Traditional business segments are under short-term pressure, with revenue declines in traditional Chinese medicine and chemical synthesis drugs [8] - The company is actively investing in innovative drug research and development, achieving breakthroughs in cutting-edge technologies [9] Financial Summary - The company expects revenue for 2025-2027 to be 2.677 billion, 3.050 billion, and 3.529 billion yuan respectively, with year-on-year growth rates of 5.6%, 13.9%, and 15.7% [10] - The net profit attributable to shareholders is projected to be 756 million, 862 million, and 997 million yuan for the same period, with growth rates of 6.9%, 14.0%, and 15.6% respectively [10] - Key financial metrics include a gross margin of 78.4% in 2025 and a return on equity (ROE) of 16.0% [12]

医药生物行业 买入（维持） 持续强化医疗服务能力提升 公 爱尔眼科（300015）2025 年中报点评 2025 年 8 月 27 日 投资要点： 司 点 事件：公司发布了2025年中报。上半年，公司实现营业总收入115.07亿元， 同比增长9.12%；实现归母净利润20.51亿元，同比增长0.05%；实现扣非后归 母净利润20.4亿元同比增长14.3%。上半年业绩整体符合预期。 评 分析师：魏红梅 SAC 执业证书编号： 点评： 表 1：公司盈利预测简表（截至 2025 年 8 月 26 日） 数据来源：iFind，东莞证券研究所 请务必阅读末页声明。 2 | 证 | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 券 | | | | | | | | | | | 研 | | | | | | | | | | | 主要数据 | 年 | 月 | 日 | 2025 | 8 | 26 | 究 | 收盘价(元) | 13.83 | | 报 | | | | | | | | | | | 总市值（亿元） | 1 ...

证券研究报告 | 2025年08月27日 三全食品（002216.SZ） 中性 上半年收入同比减少 2.7%，组织与渠道改革持续推进 三全食品 2025 年上半年实现营业总收入 35.68 亿元，同比减少 2.66%； 实现归母净利润 3.13 亿元，同比减少 5.98%；实现扣非归母净利润 2.24 亿元，同比减少 16.61%；2025Q2 实现营业总收入 13.50 亿元，同比减 少 4.39%；实现归母净利润 1.05 亿元，同比增长 1.23%；实现扣非归母 净利润 0.60 亿元，同比减少 15.89%。 B、C 端销售承压，渠道仍然偏弱。2025 年上半年公司 C 端/B 端市场收入 29/6 亿元，同比-1.5%/-8.8%，公司传统米面/创新米面/速冻调制食品/冷藏及短 保产品收入同比+0.2%/-4.7%/-15.0%/+44.5%，经销/直营/直营电商收入同 比-3.2%/-5.4%/+14.1%。从渠道和产品表现来看，速冻食品行业终端需求整 体依然处于偏弱状态，且传统渠道面临一定压力。公司聚焦品质、健康与个 性化需求，升级差异化产品矩阵，拓展全渠道，推出烤肠、丸滑类产品推动 肉制品等业 ...

证券研究报告 | 2025年08月27日 珀莱雅（603605.SH） 优于大市 二季度业绩稳健增长，多品牌矩阵协同发力 二季度业绩稳健增长。公司 2025H1 实现营收 53.62 亿/yoy+7.21%，归母净 利润 7.99 亿/yoy+13.80%；单 Q2 实现营收 30.03 亿/yoy+6.49%，归母净利 润 4.08 亿/yoy+2.36%。同时公司拟每 10 股派发现金红利 8.00 元（含税）， 分红率接近 40%，是公司历史上最高水平。同时公司同步发布筹划发行 H 股 提示性公告，主要加快海外业务发展，提升公司品牌国际知名度。 分品牌看，2025H1 主品牌珀莱雅实现营收 39.79 亿/yoy-0.08%，天猫/抖音 ROI 分别为 3.2/2.5，抖音自播/达播/其他分别占比 5.5/3.5/1，品牌持续推 新夯实大单品策略，稳固龙头地位。彩棠品牌实现收入 7.05 亿/yoy+21.11%， 延续高增态势，天猫/抖音 ROI 分别为 2/1.8，抖音自播/达播/其他分别占比 2/6.5/1.5，有望于明年进行全方位升级。Off&Relax、原色波塔等新兴品牌 表现亮眼，分别实现收 ...

Investment Rating - The report maintains a "Buy" rating for the company [2][8] Core Insights - The company reported a revenue of 9.39 billion yuan for the first half of 2025, a year-on-year increase of 6.18%, while the net profit attributable to shareholders was 796 million yuan, a decrease of 4.60% [5][8] - In Q2 2025, the company achieved a revenue of 5.12 billion yuan, a year-on-year increase of 9.89% and a quarter-on-quarter increase of 19.69%, with a net profit of 474 million yuan, up 9.80% year-on-year and 47.40% quarter-on-quarter [5][8] - The company is expanding its global footprint, with a significant increase in overseas sales, which reached 4.016 billion yuan, a year-on-year increase of 15.20%, accounting for 43% of total revenue [8] Financial Data and Profit Forecast - The company expects total revenue to grow from 18.61 billion yuan in 2025 to 22.16 billion yuan in 2027, with a compound annual growth rate (CAGR) of 9.8% [7][10] - The net profit attributable to shareholders is projected to increase from 1.447 billion yuan in 2025 to 1.782 billion yuan in 2027, reflecting a CAGR of 11.3% [7][10] - The gross margin is expected to remain stable around 23.3% to 23.7% from 2025 to 2027, with a return on equity (ROE) projected to improve from 12.6% in 2025 to 13.2% in 2027 [7][10] Company Performance and Strategic Initiatives - The company sold 204,200 forklifts in the first half of 2025, a year-on-year increase of 17.23%, with electric forklifts accounting for 68% of total sales [8] - The company is investing in R&D and has established strategic partnerships with major firms like Huawei to enhance its smart logistics capabilities [8] - The establishment of the first overseas manufacturing plant in Thailand marks a significant step in the company's global production strategy [8]

Investment Rating - The investment rating for the company is "Buy" and is maintained [6]. Core Views - The company's revenue for H1 2025 reached 12.66 billion yuan, a year-on-year increase of 10.4%, while the net profit attributable to shareholders was 1.67 billion yuan, a year-on-year decrease of 11.1% [4]. - The report anticipates a bottoming out of the fundamentals in 2025, with expectations for a rebound in 2026 and valuation improvement. Short-term factors such as old factory operating rates, order adjustments, and the launch of new factories in H2 are expected to continue to pressure net profit margins [2][4]. - The company is projected to achieve net profits of 3.51 billion, 4.16 billion, and 4.66 billion yuan for 2025, 2026, and 2027 respectively, with corresponding PE ratios of 18, 15, and 14 times [2]. Summary by Sections Revenue Performance - The company experienced a revenue increase driven by new customer acquisition, with Q2 sales volume rising by 6% to 66 million pairs and an average selling price increase of 3% to 111.3 yuan per pair [4][9]. Profitability Analysis - Q2 gross margin decreased by 7.1 percentage points year-on-year and 1.8 percentage points quarter-on-quarter to 21.1%, primarily due to the ramp-up of new factories and production line adjustments. The company maintained strong cost control, with a decrease in expense ratios [4][9]. Future Outlook - The report expects a recovery in net profit margins in Q3 due to stable tax rates and recent efficiency improvements. The combination of stabilizing old customer adjustments and the continued growth of new customers is anticipated to drive a new growth cycle [2][4].

Investment Rating - The report maintains a "Buy" rating for the company, indicating a positive outlook for its stock performance in the coming months [6]. Core Views - The company's performance is under short-term pressure, with a reported revenue of 1.29 billion yuan for the first half of 2025, representing a year-over-year decline of 8.2%. The net profit attributable to shareholders was -50.51 million yuan, a significant drop of 210.9% year-over-year [1]. - The company is focusing on high-end scientific instruments, with expectations for increased orders in the third and fourth quarters. The introduction of high-end mass spectrometry products has seen breakthroughs in various sectors, including food safety and clinical applications [3]. - A large-scale share repurchase plan has been announced, with a budget of 100 to 150 million yuan, reflecting the company's confidence in its future development [3]. Financial Performance Summary - Revenue for the first half of 2025 was 1.29 billion yuan, down 8.2% year-over-year, with Q2 revenue at 750 million yuan, down 14.2% year-over-year [1]. - The gross margin decreased by 4.1 percentage points to 40.3%, with specific margins for instruments and related software at 44.6%, and for operational services at 35.8% [2]. - Operating cash flow was negative at -110 million yuan, a decrease of 44.5% year-over-year, primarily due to reduced cash collections from sales [2]. Revenue and Profit Forecast - The company is projected to achieve revenues of 3.9 billion yuan in 2025, 4.36 billion yuan in 2026, and 4.96 billion yuan in 2027, with net profits expected to be 302 million yuan, 392 million yuan, and 487 million yuan respectively [3][5]. - The price-to-earnings (P/E) ratios are forecasted to be 32.2x for 2025, 24.8x for 2026, and 20.0x for 2027, indicating a potential for valuation improvement as earnings grow [3][5]. Market Position and Strategy - The company is concentrating resources on developing high-end analytical instruments, with a focus on increasing market share and accelerating the localization of high-end analysis equipment [3]. - The report highlights the company's leading product strength in the industry and anticipates an increase in market share due to the ongoing transformation towards high-value sectors [3].

Investment Rating - The investment rating for the company is "Outperform the Market" [4][24]. Core Views - The company achieved a 60% year-on-year increase in net profit attributable to shareholders in H1 2025, reaching 8.67 billion yuan, driven by rising copper and cobalt prices alongside increased production [6][24]. - The company is actively pursuing a goal of reaching a copper production capacity of 1 million tons, with significant projects like KFM Phase II and TFM Phase III expected to commence production after 2027 [20][24]. - The report highlights that the company has successfully completed the acquisition of the Ecuadorian gold mine and is progressing with its development, aiming for production before 2029 [6][24]. Financial Performance - In Q2 2025, the company reported a net profit of 4.73 billion yuan, a 41.2% increase year-on-year and a 19.7% increase quarter-on-quarter [6][24]. - The copper production in Q2 2025 was 183,000 tons, a 10% increase year-on-year, while copper sales reached 199,000 tons, marking a 6.7% year-on-year increase and a significant 60.5% quarter-on-quarter increase [2][7]. - The company expects net profits for 2025-2027 to be 16.315 billion, 17.752 billion, and 18.924 billion yuan respectively, with year-on-year growth rates of 20.6%, 8.8%, and 6.6% [24][25]. Cost and Pricing - The copper production cost in Q2 2025 was calculated at 32,015 yuan per ton, indicating potential for cost reduction in the future [8][9]. - The report indicates that for every 5,000 yuan increase in copper price, the company's net profit would increase by 1.4 billion yuan [20][24]. Market Position and Future Outlook - The company is positioned as one of the few large copper mining companies maintaining high growth in copper production, with expectations to reach 800,000 to 1 million tons by 2028 [20][24]. - The report emphasizes the company's strong operational leverage to copper and cobalt prices, which could significantly enhance profitability [24].

证券研究报告·公司点评报告·保险Ⅱ [Table_Tag] [Table_Summary] 投资要点 2025 年 08 月 27 日 证券分析师 孙婷 执业证书：S0600524120001 sunt@dwzq.com.cn 证券分析师 曹锟 中国平安（601318） 2025 年中报点评：银保扩张推动 NBV 快速 增长，显著增配股票投资 买入（维持） | [Table_EPS] 盈利预测与估值 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入（百万元） | 913789 | 1028925 | 1060775 | 1124317 | 1200770 | | 同比（%） | 3.8% | 12.6% | 3.1% | 6.0% | 6.8% | | 归母净利润（百万元） | 85665 | 126607 | 129672 | 142693 | 163810 | | 同比（%） | -22.8% | 47.8% | 2.4% | 10.0% | 14.8% | | 每股 EV（元/股 ...